Research Report University Hospital for clinical assessment BFS-AS-306

Abstract

A 12-Week Efficacy and Safety Evaluation of Budesonidel/Formoterol SPIROMAX(R) 160/4.5 mcg Inhalation Powder Versus SYMBICORT(R) TURBOHALER(R) 200/6 mcg in Adult and Adolescent Patients With Persistent Asthma

Keywords

• Persistent Asthma
• Spiromax budenosid/formoterol 160/4,5 mcg